相关实验视频

Updated: Jul 12, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

3.1K

复发性耐火性多发性骨髓瘤与中枢神经系统参与成功治疗Elranatamab:第一个报告的病例

Yasa Gul Mutlu1, Sureyya Yıgıt Kaya1, Senem Maral1

  • 1Department of Hematology, Istanbul Medipol University, Istanbul, Türkiye.

Frontiers in immunology
|October 30, 2023
PubMed
概括

多发性骨髓瘤中中枢神经系统的参与是罕见的. 双特异性抗体Elranatamab在治疗这种具有挑战性的并发症方面表现有前途,为患者提供了新的希望.

关键词:
这就是为什么BCMABCMABCMA.中央国家安全局的参与.埃尔拉纳塔马巴的意思是两种特定的Ab Ab.多发性骨髓瘤是多发性骨髓瘤的一种.

更多相关视频

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

5.6K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K